Effects of Rifaximin on Gut Microbiota and Emotion
Clinical trial NCT05587036 · RECRUITING
Trial details
- NCT number
- NCT05587036
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-02
- Primary completion
- 2025-07-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.